These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2531581)

  • 1. Novel peptides derived from a region of local homology between uteroglobin and lipocortin-1 inhibit platelet aggregation and secretion.
    Vostal JG; Mukherjee AB; Miele L; Shulman NR
    Biochem Biophys Res Commun; 1989 Nov; 165(1):27-36. PubMed ID: 2531581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
    Märki F; Pfeilschifter J; Rink H; Wiesenberg I
    FEBS Lett; 1990 May; 264(2):171-5. PubMed ID: 2141575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
    Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
    Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the thrombin-platelet reactions by DuP 714.
    Chiu AT; Mousa SA; Pease LJ; Roscoe WA; Bozarth JM; Reilly TM; Smith RD; Timmermans PB
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1500-8. PubMed ID: 1930190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I.
    Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
    Nature; 1988 Oct; 335(6192):726-30. PubMed ID: 2971881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation.
    Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thrombin-induced platelet aggregation by uteroglobin.
    Manjunath R; Levin SW; Kumaroo KK; Butler JD; Donlon JA; Horne M; Fujita R; Schumacher UK; Mukherjee AB
    Biochem Pharmacol; 1987 Mar; 36(5):741-6. PubMed ID: 3827955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation.
    Chao BH; Jakubowski JA; Savage B; Chow EP; Marzec UM; Harker LA; Maraganore JM
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8050-4. PubMed ID: 2510158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides.
    Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
    Adv Exp Med Biol; 1990; 279():137-60. PubMed ID: 2151414
    [No Abstract]   [Full Text] [Related]  

  • 11. Arachidonate-induced fibrinogen binding to thrombin-degranulated rabbit platelets is independent of released ADP.
    Harfenist EJ; Guccione MA; Packham MA; Kinlough-Rathbone RL; Mustard JF
    Blood; 1982 May; 59(5):956-62. PubMed ID: 6280787
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.
    van Binsbergen J; Slotboom AJ; Aarsman AJ; de Haas GH
    FEBS Lett; 1989 Apr; 247(2):293-7. PubMed ID: 2523817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uteroglobin inhibits phospholipase A2 activity.
    Levin SW; Butler JD; Schumacher UK; Wightman PD; Mukherjee AB
    Life Sci; 1986 May; 38(20):1813-9. PubMed ID: 3084897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of the 47 KDa protein in gamma-thrombin-stimulated human platelets does not activate phospholipase A2: evidence against lipocortin.
    Crouch MF; Lapetina EG
    Biochem Biophys Res Commun; 1986 Dec; 141(2):459-65. PubMed ID: 2948506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins.
    Lloret S; Moreno JJ
    Biochem Pharmacol; 1992 Oct; 44(7):1437-41. PubMed ID: 1417964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of lipocortin I and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors.
    Haigler HT; Schlaepfer DD; Burgess WH
    J Biol Chem; 1987 May; 262(14):6921-30. PubMed ID: 3032981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
    Lau LF; Pumiglia K; Côté YP; Feinstein MB
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.